Prior Auth Required
0287U - cancer recurrence, reported as a categorical risk result (low, intermediate, high)
This procedure appears on the selected insurer prior authorization source.
Prior authorizationPrior Auth Required
Procedure / Servicecancer recurrence, reported as a categorical risk result (low, intermediate, high)
Procedure / Service Description
Oncology, response to radiation, cell-free DNA, quantitative branched chain DNA - Oncology (thyroid), DNA and mRNA, next-generation sequencing analysis of 112 genes, fine needle aspirate or formalin-fixed paraffin-embedded (FFPE) tissue, algorithmic prediction of 0287U cancer recurrence, reported as a categorical risk result (low, intermediate, high) Anoscopy, with delivery of thermal energy to the muscle of the anal canal (eg, for fecal 0288T incontinence)
Likely documents
- Confirm benefit details
- Submit clinical notes if requested by the plan
Next actions
- Confirm the current plan policy before submission.
- Use the insurer authorization workflow for this listed code.